POINT Biopharma Global Inc.
POINT Biopharma Global Inc. (PNT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pnt · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for POINT Biopharma Global Inc. (PNT) measures how much investors pay for each dollar of the company's trailing earnings. PNT's current PE ratio of 12.03x is calculated by dividing its stock price of $12.50 by its TTM earnings per share of $1.04. +71.4% elevated vs 5Y avg 7.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2019 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
POINT Biopharma Global Inc.You PNT | $1.3B | 12.03x | — | $1.04 |
 Crescent Biopharma, Inc. CBIO | $500M | N/A | — | -$14.78 |
 CinCor Pharma, Inc. CINC | $1.3B | N/A | — | -$1.42 |
 CTI BioPharma Corp. CTIC | $1.2B | N/A | — | -$0.79 |
 EQRx, Inc. EQRX | $1.1B | 5.68x | — | $0.43 |
 Ethzilla Corp. ETHZ | $56M | N/A | — | -$5517.71 |
 Gracell Biotechnologies Inc. GRCL | $198M | N/A | — | -$44.87 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 7.02x | $1.04 | — | |
2021-12-31 FY2021 | — | $-0.62 | — | |
2020-12-31 FY2020 | — | $-0.34 | — | |
2019-12-31 FY2019 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for POINT Biopharma Global Inc. (PNT) measures how much investors pay for each dollar of the company's trailing earnings. PNT's current PE ratio of 12.03x is calculated by dividing its stock price of $12.50 by its TTM earnings per share of $1.04.
Frequently asked questions
PNT pe ratio · 6 questionsPNT's current PE ratio is 12.03x as of 2026-06-09, based on a stock price of $12.50 and TTM EPS of $1.04. Data sourced from Financial Modeling Prep via PNT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · POINT Biopharma Global Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09